(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMALGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHARMALGEN

ST13

US500000073187537

Class

5

Filing

73187537

Registration

1129117

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

03/13/2020

Trademark type

Word

Nice classes

5

Filing date

09/29/1978

Registration date

01/15/1980

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/13/2020

Last transaction

03/13/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

07/27/1978

First use in commerce

07/27/1978

Drawing code

1

Owner type

03

Owner location

HORSHOLM, DK

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

ALK-ABELLO A/S
PHARMACIA INC.

Representatives

B. BRETT HEAVNER FINNEGAN HENDERSON FARABOW GARRETT ET AL

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

PHARMACEUTICAL PREPARATION BEING AN ALLERGEN EXTRACT

Publications

History of USPTO decisions and trademark events.

18 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/13/2020

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

03/13/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/13/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/12/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

01/17/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/15/2019

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/04/2010

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

05/04/2010

8OKT

REGISTERED - SEC. 8 (10-YR) ACCEPTED/CHECK RECORD FOR SEC. 9

02/01/2010

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

01/15/2010

MAIL

PAPER RECEIVED

01/15/2010

CFIT

CASE FILE IN TICRS

02/08/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/02/2005

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/10/2000

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/10/2000

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

01/15/2000

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/18/1986

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

01/02/1986

Continuous trademark protection

Get notified about every new filing that threatens PHARMALGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.